Today, Excelya announced the appointment of Nathalie Doize as COO and Rudolph Rosenberg as CFO of Excelya. After strong growth in 2020, Nathalie will aim to harmonize operations across Europe and oversee project delivery while Excelya aims to become the highest quality contract research organization in Europe. Rudolph Rosenberg will set the group’s financial strategy and help Excelya grow its business globally.
Nathalie has more over 30 years of drug development experience for both CROs and pharmaceutical companies. Nathalie joins Excelya from Syneos Health, where she served as Vice President of Operations and was responsible for the operations and supervision of operational teams in Europe and Asia-Pacific. Previously, she held various seniority escalation positions, including department leadership for Mapi Group, inVentiv Health Clinical and i3 Research.
Rudolph joins Excelya after more more than 20 years at the head of financial organizations Technology sector. Rudolph’s experience includes scaling up mid-sized startups such as Groupe Allo-Media and Nibelis as CFO, as well as supporting the expansion and structuring into EMEA of large groups such as Dell Technologies.
Alan Morgan, CEO of Excelya: “I am delighted to welcome Nathalie and Rudolph. Nathalie’s in-depth expertise in the operations of contract research organizations will enable us to deliver on our promise of excellence as we become a…
News Highlights Finance
- Headline: Nathalie Doize is appointed Director of Operations
- Check all news and articles from the Finance news updates.